{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:07:16Z","timestamp":1778998036573,"version":"3.51.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:00:00Z","timestamp":1723334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:00:00Z","timestamp":1723334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ekam Imaging, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-69597-9","type":"journal-article","created":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T11:01:56Z","timestamp":1723374116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Developmental changes in brain structure and function following exposure to oral LSD during adolescence"],"prefix":"10.1038","volume":"14","author":[{"given":"Lila","family":"Harris-Blum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepti","family":"Athreya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen P.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig F.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,11]]},"reference":[{"key":"69597_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1055\/a-1310-3990","volume":"54","author":"DE Nichols","year":"2021","unstructured":"Nichols, D. E. & Walter, H. The history of psychedelics in psychiatry. Pharmacopsychiatry 54, 151\u2013166 (2021).","journal-title":"Pharmacopsychiatry"},{"key":"69597_CR2","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1038\/npp.2017.84","volume":"42","author":"RL Carhart-Harris","year":"2017","unstructured":"Carhart-Harris, R. L. & Goodwin, G. M. The therapeutic potential of psychedelic drugs: Past, present, and future. Neuropsychopharmacology 42, 2105\u20132113 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"69597_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109174","volume":"216","author":"S Ross","year":"2022","unstructured":"Ross, S. et al. Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care. Neuropharmacology 216, 109174 (2022).","journal-title":"Neuropharmacology"},{"key":"69597_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fphar.2017.00279","volume":"8","author":"CF Ferris","year":"2017","unstructured":"Ferris, C. F., Kulkarni, P., Yee, J. R., Nedelman, M. & de Jong, I. E. M. The serotonin receptor 6 antagonist idalopirdine and acetylcholinesterase inhibitor donepezil have synergistic effects on brain activity\u2014A functional MRI study in the awake rat. Front. Pharmacol. 8, 279 (2017).","journal-title":"Front. Pharmacol."},{"key":"69597_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neuroscience.2018.11.042","volume":"398","author":"SC Iriah","year":"2019","unstructured":"Iriah, S. C. et al. Oxycodone exposure: A magnetic resonance imaging study in response to acute and chronic oxycodone treatment in rats. Neuroscience 398, 88\u2013101 (2019).","journal-title":"Neuroscience"},{"key":"69597_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.1035","volume":"10","author":"K Kawazoe","year":"2022","unstructured":"Kawazoe, K. et al. Dose-dependent effects of esketamine on brain activity in awake mice: A BOLD phMRI study. Pharmacol. Res. Perspect. 10, e01035 (2022).","journal-title":"Pharmacol. Res. Perspect."},{"key":"69597_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12967-021-02891-6","volume":"19","author":"AH Sadaka","year":"2021","unstructured":"Sadaka, A. H. et al. Cannabidiol has a unique effect on global brain activity: A pharmacological, functional MRI study in awake mice. J. Transl. Med. 19, 220 (2021).","journal-title":"J. Transl. Med."},{"key":"69597_CR8","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1073\/pnas.1518377113","volume":"113","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris, R. L. et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc. Natl. Acad. Sci. USA 113, 4853\u20134858 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69597_CR9","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/acps.12818","volume":"136","author":"F Muller","year":"2017","unstructured":"Muller, F. et al. Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations. Acta Psychiatr. Scand. 136, 648\u2013657 (2017).","journal-title":"Acta Psychiatr. Scand."},{"key":"69597_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.7554\/eLife.35082","volume":"7","author":"KH Preller","year":"2018","unstructured":"Preller, K. H. et al. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor. Elife 7, 6 (2018).","journal-title":"Elife"},{"key":"69597_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.nicl.2018.03.005","volume":"18","author":"F Muller","year":"2018","unstructured":"Muller, F., Dolder, P. C., Schmidt, A., Liechti, M. E. & Borgwardt, S. Altered network hub connectivity after acute LSD administration. Neuroimage Clin. 18, 694\u2013701 (2018).","journal-title":"Neuroimage Clin."},{"key":"69597_CR12","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1073\/pnas.1815129116","volume":"116","author":"KH Preller","year":"2019","unstructured":"Preller, K. H. et al. Effective connectivity changes in LSD-induced altered states of consciousness in humans. Proc. Natl. Acad. Sci. USA 116, 2743\u20132748 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69597_CR13","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1523\/JNEUROSCI.1939-17.2018","volume":"38","author":"KH Preller","year":"2018","unstructured":"Preller, K. H. et al. Role of the 5-HT(2A) receptor in self- and other-initiated social interaction in lysergic acid diethylamide-induced states: A pharmacological fMRI study. J. Neurosci. 38, 3603\u20133611 (2018).","journal-title":"J. Neurosci."},{"key":"69597_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","volume":"235","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris, R. L. et al. Psilocybin with psychological support for treatment-resistant depression: Six-month follow-up. Psychopharmacology (Berl) 235, 399\u2013408 (2018).","journal-title":"Psychopharmacology (Berl)"},{"key":"69597_CR15","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross, S. et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. J. Psychopharmacol. 30, 1165\u20131180 (2016).","journal-title":"J. Psychopharmacol."},{"key":"69597_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0269881114555249","volume":"29","author":"P Gasser","year":"2015","unstructured":"Gasser, P., Kirchner, K. & Passie, T. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects. J. Psychopharmacol. 29, 57\u201368 (2015).","journal-title":"J. Psychopharmacol."},{"key":"69597_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","volume":"43","author":"MW Johnson","year":"2017","unstructured":"Johnson, M. W., Garcia-Romeu, A. & Griffiths, R. R. Long-term follow-up of psilocybin-facilitated smoking cessation. Am. J. Drug Alcohol Abuse 43, 55\u201360 (2017).","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"69597_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41386-022-01389-z","volume":"48","author":"AE Calder","year":"2023","unstructured":"Calder, A. E. & Hasler, G. Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology 48, 104\u2013112 (2023).","journal-title":"Neuropsychopharmacology"},{"key":"69597_CR19","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly, C. et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 23, 3170\u20133182 (2018).","journal-title":"Cell Rep."},{"key":"69597_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2021.173129","volume":"203","author":"MLS Bates","year":"2021","unstructured":"Bates, M. L. S. & Trujillo, K. A. Use and abuse of dissociative and psychedelic drugs in adolescence. Pharmacol. Biochem. Behav. 203, 173129 (2021).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"69597_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1469-7610.2006.01611.x","volume":"47","author":"S-J Blakemore","year":"2006","unstructured":"Blakemore, S.-J. & Choudhury, S. Development of the adolescent brain: Implications for executive function and social cognition. J. Child Psychol. Psychiatry 47, 296\u2013312 (2006).","journal-title":"J. Child Psychol. Psychiatry"},{"key":"69597_CR22","doi-asserted-by":"publisher","first-page":"8819","DOI":"10.1523\/JNEUROSCI.21-22-08819.2001","volume":"21","author":"ER Sowell","year":"2001","unstructured":"Sowell, E. R., Thompson, P. M., Tessner, K. D. & Toga, A. W. Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: Inverse relationships during postadolescent brain maturation. J. Neurosci. 21, 8819\u20138829 (2001).","journal-title":"J. Neurosci."},{"key":"69597_CR23","doi-asserted-by":"publisher","first-page":"13281","DOI":"10.1073\/pnas.1105108108","volume":"108","author":"Z Petanjek","year":"2011","unstructured":"Petanjek, Z. et al. Extraordinary neoteny of synaptic spines in the human prefrontal cortex. Proc. Natl. Acad. Sci. USA 108, 13281\u201313286 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69597_CR24","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1111\/add.15987","volume":"117","author":"O Livne","year":"2022","unstructured":"Livne, O., Shmulewitz, D., Walsh, C. & Hasin, D. S. Adolescent and adult time trends in US hallucinogen use, 2002\u201319: Any use, and use of ecstasy, LSD and PCP. Addiction 117, 3099\u20133109 (2022).","journal-title":"Addiction"},{"key":"69597_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neubiorev.2016.05.020","volume":"70","author":"RD Romeo","year":"2016","unstructured":"Romeo, R. D., Patel, R., Pham, L. & So, V. M. Adolescence and the ontogeny of the hormonal stress response in male and female rats and mice. Neurosci. Biobehav. Rev. 70, 206\u2013216 (2016).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"69597_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412 (2010).","journal-title":"PLoS Biol."},{"key":"69597_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.phrs.2016.08.022","volume":"113","author":"D De Gregorio","year":"2016","unstructured":"De Gregorio, D. et al. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT(1A), D(2) and TAAR(1) receptors. Pharmacol. Res. 113, 81\u201391 (2016).","journal-title":"Pharmacol. Res."},{"key":"69597_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1177\/0269881121991569","volume":"35","author":"A Inserra","year":"2021","unstructured":"Inserra, A. et al. Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice. J. Psychopharmacol. 35, 469\u2013482 (2021).","journal-title":"J. Psychopharmacol."},{"key":"69597_CR29","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/252586a0","volume":"252","author":"L Pieri","year":"1974","unstructured":"Pieri, L., Pieri, M. & Haefely, W. LSD as an agonist of dopamine receptors in the striatum. Nature 252, 586\u2013588 (1974).","journal-title":"Nature"},{"key":"69597_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1073\/pnas.2020705118","volume":"118","author":"D De Gregorio","year":"2021","unstructured":"De Gregorio, D. et al. Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission. Proc. Natl. Acad. Sci. USA 118, 34 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69597_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fneur.2014.00094","volume":"5","author":"CF Ferris","year":"2014","unstructured":"Ferris, C. F. et al. Studies on the Q175 knock-in model of Huntington\u2019s disease using functional imaging in awake mice: Evidence of olfactory dysfunction. Front. Neurol. 5, 94 (2014).","journal-title":"Front. Neurol."},{"key":"69597_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13169","volume":"27","author":"JR Coleman","year":"2022","unstructured":"Coleman, J. R. et al. Changes in brain structure and function following chronic exposure to inhaled vaporised cannabis during periadolescence in female and male mice: A multimodal MRI study. Addict. Biol. 27, e13169 (2022).","journal-title":"Addict. Biol."},{"key":"69597_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.798704","volume":"12","author":"LD Otto","year":"2022","unstructured":"Otto, L. D. et al. Paclitaxel chemotherapy elicits widespread brain anisotropy changes in a comprehensive mouse model of breast cancer survivorship: Evidence from in vivo diffusion weighted imaging. Front. Oncol. 12, 798704 (2022).","journal-title":"Front. Oncol."},{"key":"69597_CR34","doi-asserted-by":"publisher","first-page":"1139309","DOI":"10.3389\/fnins.2023.1139309","volume":"17","author":"A Taylor","year":"2023","unstructured":"Taylor, A. et al. Chronic exposure to inhaled vaporized cannabis high in Delta9-THC alters brain structure in adult female mice. Front. Neurosci. 17, 1139309 (2023).","journal-title":"Front. Neurosci."},{"key":"69597_CR35","doi-asserted-by":"publisher","first-page":"1055433","DOI":"10.3389\/fnagi.2023.1055433","volume":"15","author":"AH Sadaka","year":"2023","unstructured":"Sadaka, A. H. et al. Effects of inhaled cannabis high in Delta9-THC or CBD on the aging brain: A translational MRI and behavioral study. Front. Aging Neurosci. 15, 1055433 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"69597_CR36","first-page":"576","volume":"7","author":"RJ Ortiz","year":"2022","unstructured":"Ortiz, R. J. et al. Functional connectivity differences between two culturally distinct prairie vole populations: Insights into the prosocial network. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 7, 576\u2013587 (2022).","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"69597_CR37","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fneur.2017.00200","volume":"8","author":"M Gorges","year":"2017","unstructured":"Gorges, M. et al. Functional connectivity mapping in the animal model: Principles and applications of resting-state fMRI. Front. Neurol. 8, 200 (2017).","journal-title":"Front. Neurol."},{"key":"69597_CR38","doi-asserted-by":"publisher","first-page":"10183","DOI":"10.1523\/JNEUROSCI.1020-12.2012","volume":"32","author":"Z Liang","year":"2012","unstructured":"Liang, Z., King, J. & Zhang, N. Intrinsic organization of the anesthetized brain. J. Neurosci. 32, 10183\u201310191 (2012).","journal-title":"J. Neurosci."},{"key":"69597_CR39","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.neuroimage.2009.01.007","volume":"45","author":"BA Poser","year":"2009","unstructured":"Poser, B. A. & Norris, D. G. Investigating the benefits of multi-echo EPI for fMRI at 7 T. Neuroimage 45, 1162\u20131172 (2009).","journal-title":"Neuroimage"},{"key":"69597_CR40","doi-asserted-by":"publisher","first-page":"E548","DOI":"10.1503\/jpn.200191","volume":"46","author":"SC Iriah","year":"2021","unstructured":"Iriah, S. C. et al. The utility of maraviroc, an antiretroviral agent used to treat HIV, as treatment for opioid abuse? Data from MRI and behavioural testing in rats. J. Psychiatry Neurosci. 46, E548\u2013E558 (2021).","journal-title":"J. Psychiatry Neurosci."},{"key":"69597_CR41","doi-asserted-by":"crossref","unstructured":"Bastian, M., Heymann, S. & Jacomy, M. Gephi: An open source software for exploring and manipulating networks. In International AAAI Conference on Weblogs and Social Media (2009).","DOI":"10.1609\/icwsm.v3i1.13937"},{"key":"69597_CR42","doi-asserted-by":"publisher","first-page":"R1401","DOI":"10.1016\/j.cub.2020.09.069","volume":"30","author":"JB Smith","year":"2020","unstructured":"Smith, J. B., Lee, A. K. & Jackson, J. The claustrum. Curr. Biol. 30, R1401\u2013R1406 (2020).","journal-title":"Curr. Biol."},{"key":"69597_CR43","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","volume":"78","author":"Y Schmid","year":"2015","unstructured":"Schmid, Y. et al. Acute effects of lysergic acid diethylamide in healthy subjects. Biol. Psychiatry 78, 544\u2013553 (2015).","journal-title":"Biol. Psychiatry"},{"key":"69597_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0169-328X(03)00029-9","volume":"111","author":"CD Nichols","year":"2003","unstructured":"Nichols, C. D., Garcia, E. E. & Sanders-Bush, E. Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration. Brain Res. Mol. Brain Res. 111, 182\u2013188 (2003).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"69597_CR45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1469-8749.2002.tb00253.x","volume":"44","author":"ER Sowell","year":"2002","unstructured":"Sowell, E. R., Trauner, D. A., Gamst, A. & Jernigan, T. L. Development of cortical and subcortical brain structures in childhood and adolescence: A structural MRI study. Dev. Med. Child Neurol. 44, 4\u201316 (2002).","journal-title":"Dev. Med. Child Neurol."},{"key":"69597_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4939-8994-2_9","volume":"1916","author":"AK Kraeuter","year":"2019","unstructured":"Kraeuter, A. K., Guest, P. C. & Sarnyai, Z. The open field test for measuring locomotor activity and anxiety-like behavior. Methods Mol. Biol. 1916, 99\u2013103 (2019).","journal-title":"Methods Mol. Biol."},{"key":"69597_CR47","doi-asserted-by":"crossref","unstructured":"Lueptow, L.M. Novel object recognition test for the investigation of learning and memory in mice. J. Vis. Exp. (2017).","DOI":"10.3791\/55718-v"},{"key":"69597_CR48","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.bbr.2010.05.034","volume":"214","author":"PH Botton","year":"2010","unstructured":"Botton, P. H. et al. Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice. Behav. Brain Res. 214, 254\u2013259 (2010).","journal-title":"Behav. Brain Res."},{"key":"69597_CR49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.nlm.2013.06.014","volume":"105","author":"SJ Moore","year":"2013","unstructured":"Moore, S. J., Deshpande, K., Stinnett, G. S., Seasholtz, A. F. & Murphy, G. G. Conversion of short-term to long-term memory in the novel object recognition paradigm. Neurobiol. Learn Mem. 105, 174\u2013185 (2013).","journal-title":"Neurobiol. Learn Mem."},{"key":"69597_CR50","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1037\/0735-7044.119.4.884","volume":"119","author":"G Hale","year":"2005","unstructured":"Hale, G. & Good, M. Impaired visuospatial recognition memory but normal object novelty detection and relative familiarity judgments in adult mice expressing the APPswe Alzheimer\u2019s disease mutation. Behav. Neurosci. 119, 884\u2013891 (2005).","journal-title":"Behav. Neurosci."},{"key":"69597_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134565","volume":"714","author":"TR Morrison","year":"2020","unstructured":"Morrison, T. R. et al. Treating head injury using a novel vasopressin 1a receptor antagonist. Neurosci. Lett. 714, 134565 (2020).","journal-title":"Neurosci. Lett."},{"key":"69597_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2022.114148","volume":"356","author":"IM Ornelas","year":"2022","unstructured":"Ornelas, I. M. et al. Nootropic effects of LSD: Behavioral, molecular and computational evidence. Exp. Neurol. 356, 114148 (2022).","journal-title":"Exp. Neurol."},{"key":"69597_CR53","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","volume":"152","author":"S Dutta","year":"2016","unstructured":"Dutta, S. & Sengupta, P. Men and mice: Relating their ages. Life Sci. 152, 244\u2013248 (2016).","journal-title":"Life Sci."},{"key":"69597_CR54","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/hbm.21092","volume":"32","author":"A Messe","year":"2011","unstructured":"Messe, A. et al. Diffusion tensor imaging and white matter lesions at the subacute stage in mild traumatic brain injury with persistent neurobehavioral impairment. Hum. Brain Mapp. 32, 999\u20131011 (2011).","journal-title":"Hum. Brain Mapp."},{"key":"69597_CR55","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.brainresbull.2020.10.001","volume":"165","author":"P Kulkarni","year":"2020","unstructured":"Kulkarni, P. et al. Evidence of early vasogenic edema following minor head impact that can be reduced with a vasopressin V1a receptor antagonist. Brain Res. Bull. 165, 218\u2013227 (2020).","journal-title":"Brain Res. Bull."},{"key":"69597_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125748","volume":"10","author":"P Kulkarni","year":"2015","unstructured":"Kulkarni, P. et al. Use of anisotropy, 3D segmented atlas, and computational analysis to identify gray matter subcortical lesions common to concussive injury from different sites on the cortex. PLoS One 10, e0125748 (2015).","journal-title":"PLoS One"},{"key":"69597_CR57","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/RCT.0b013e318261e913","volume":"36","author":"FE De Belder","year":"2012","unstructured":"De Belder, F. E. et al. Diffusion tensor imaging provides an insight into the microstructure of meningiomas, high-grade gliomas, and peritumoral edema. J. Comput. Assist. Tomogr. 36, 577\u2013582 (2012).","journal-title":"J. Comput. Assist. Tomogr."},{"key":"69597_CR58","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41386-020-00883-6","volume":"46","author":"F Holze","year":"2021","unstructured":"Holze, F. et al. Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology 46, 537\u2013544 (2021).","journal-title":"Neuropsychopharmacology"},{"key":"69597_CR59","first-page":"6","volume":"19","author":"PC Dolder","year":"2015","unstructured":"Dolder, P. C., Schmid, Y., Haschke, M., Rentsch, K. M. & Liechti, M. E. Pharmacokinetics and concentration\u2013effect relationship of oral LSD in humans. Int. J. Neuropsychopharmacol. 19, 6 (2015).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"69597_CR60","doi-asserted-by":"publisher","first-page":"117906951880050","DOI":"10.1177\/1179069518800508","volume":"12","author":"DE Olson","year":"2018","unstructured":"Olson, D. E. Psychoplastogens: A promising class of plasticity-promoting neurotherapeutics. J. Exp. Neurosci. 12, 1179069518800508 (2018).","journal-title":"J. Exp. Neurosci."},{"key":"69597_CR61","doi-asserted-by":"publisher","first-page":"8836","DOI":"10.1523\/JNEUROSCI.23-26-08836.2003","volume":"23","author":"J Gonzalez-Maeso","year":"2003","unstructured":"Gonzalez-Maeso, J. et al. Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. J. Neurosci. 23, 8836\u20138843 (2003).","journal-title":"J. Neurosci."},{"key":"69597_CR62","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","volume":"17","author":"VA Vaidya","year":"1997","unstructured":"Vaidya, V. A., Marek, G. J., Aghajanian, G. K. & Duman, R. S. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J. Neurosci. 17, 2785\u20132795 (1997).","journal-title":"J. Neurosci."},{"key":"69597_CR63","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1177\/1073858416667720","volume":"23","author":"DS Bassett","year":"2017","unstructured":"Bassett, D. S. & Bullmore, E. T. Small-world brain networks revisited. Neuroscientist 23, 499\u2013516 (2017).","journal-title":"Neuroscientist"},{"key":"69597_CR64","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cub.2016.02.010","volume":"26","author":"E Tagliazucchi","year":"2016","unstructured":"Tagliazucchi, E. et al. Increased global functional connectivity correlates with LSD-induced ego dissolution. Curr. Biol. 26, 1043\u20131050 (2016).","journal-title":"Curr. Biol."},{"key":"69597_CR65","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.nlm.2014.01.006","volume":"109","author":"S Akkerman","year":"2014","unstructured":"Akkerman, S., Blokland, A. & Prickaerts, J. Mind the gap: Delayed manifestation of long-term object memory improvement by phosphodiesterase inhibitors. Neurobiol. Learn. Mem. 109, 139\u2013143 (2014).","journal-title":"Neurobiol. Learn. Mem."},{"key":"69597_CR66","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","volume":"13","author":"M Antunes","year":"2012","unstructured":"Antunes, M. & Biala, G. The novel object recognition memory: Neurobiology, test procedure, and its modifications. Cogn. Process 13, 93\u2013110 (2012).","journal-title":"Cogn. Process"},{"key":"69597_CR67","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1038\/nprot.2013.155","volume":"8","author":"M Leger","year":"2013","unstructured":"Leger, M. et al. Object recognition test in mice. Nat. Protoc. 8, 2531\u20132537 (2013).","journal-title":"Nat. Protoc."},{"key":"69597_CR68","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13143","volume":"27","author":"H de Wit","year":"2022","unstructured":"de Wit, H., Molla, H. M., Bershad, A., Bremmer, M. & Lee, R. Repeated low doses of LSD in healthy adults: A placebo-controlled, dose-response study. Addict. Biol. 27, e13143 (2022).","journal-title":"Addict. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69597-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69597-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69597-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T14:05:59Z","timestamp":1723644359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69597-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,11]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["69597"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-69597-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3979084\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,11]]},"assertion":[{"value":"22 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CFF and PPK have a partnership interest in Ekam Solutions a company that develops 3D MRI atlases and makes radiofrequency electronics and holders for awake animal imaging. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18632"}}